| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-09 |
| mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-08 |
| mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-08 |
| mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
| mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
3e-07 |
| mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-07 |
| mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
4e-07 |
| mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-07 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-07 |